comparemela.com

Latest Breaking News On - Therapeutics panel - Page 1 : comparemela.com

DGAP-News: Immunic, Inc to Participate in Industry and Investor Conferences in March

DGAP-News: Immunic, Inc. to Participate in Industry and Investor Conferences in March Immunic, Inc. to Participate in Industry and Investor Conferences in March 02.03.2021 / 12:30 Immunic, Inc. to Participate in Industry and Investor Conferences in March NEW YORK, March 2, 2021 - Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced management s participation in the following industry and investor conferences in March: - March 8-9: 2nd Annual European HealthTech CEO Forum. Daniel Vitt, Ph.D., Chief Executive Officer and President of Immunic, will participate in the Advanced Therapeutics Panel as part of the Pandemic Response Day on Tuesday, March 9, at 1:30 pm CET (7:30 am ET) to discuss the potential of IMU-838 as a treatment option for COVID-19.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.